ESC Premium Access

Efficacy of ARNI in real-world

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Presentation

About the speaker

Professor Michael Fu

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)
1 presentation
0 follower

8 more presentations in this session

EmDia - Empagliflozin and left ventricular diastolic function

Speaker: Doctor P. Wild (Mainz, DE)

Thumbnail

DYNAMIC - Riociguat in patients with pulmonary hypertension and heart failure with preserved ejection fraction

Speaker: Professor D. Bondermann (Vienna, AT)

Thumbnail

High-sensitivity cardiac troponin in DAPA-HF

Speaker: Doctor D. Berg (Boston, US)

Thumbnail

Gestational hypertensive disorders in PPCM.

Speaker: Doctor A. Jackson (Glasgow, GB)

Thumbnail

The HUNT for HF risk score

Speaker: Doctor A. Ofstad (Gjettum, NO)

Thumbnail

Access the full session

Latest Science in Heart Failure

Speakers: Professor M. Fu, Doctor P. Wild, Professor D. Bondermann, Doctor D. Berg, Doctor A. Jackson...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

ESC Premium Access

Diagnostic accuracy and reclassification potential of the acoustic CADScor algorithm in intermediate risk patients with suspected coronary artery disease

27 August 2021

This platform is supported by

logo Novo Nordisk